J L Selam
Overview
Explore the profile of J L Selam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
356
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Charles M, Selam J
Metab Syndr Relat Disord
. 2008 Mar;
3(3):203-12.
PMID: 18370788
The most common cause of death in diabetes is cardiovascular. Diabetic nephropathy has an important role in cardiovascular disease among susceptible diabetic patients. What is not well appreciated is that...
2.
Dufaitre-Patouraux L, Riveline J, Renard E, Melki V, Belicar-Schaepelynck P, Selam J, et al.
Diabetes Metab
. 2006 Nov;
32(5 Pt 1):427-32.
PMID: 17110897
Aim: The purpose of this national multicenter prospective study by the French EVADIAC group was to investigate the possibility that continuous intraperitoneal insulin infusion using an implanted pump (CIpii) increases...
3.
Radermecker R, Selam J
Rev Med Liege
. 2005 Jul;
60(5-6):355-60.
PMID: 16035294
Since the discovery of insulin and its use in diabetes care, patients, physicians and nurses dream of another way of insulin administration than the subcutaneous injections actually used. Different types...
4.
Gin H, Renard E, Melki V, Boivin S, Schaepelynck-Belicar P, Guerci B, et al.
Diabetes Metab
. 2004 Jan;
29(6):602-7.
PMID: 14707889
Objective: To report a long-term multicentre experience with implantable insulin pumps in type 1 diabetic patients, and to test safety and accuracy of the systems following improvements in infused insulin...
5.
MBemba J, Cynober L, de Bandt P, Taverna M, Chevalier A, Bardin C, et al.
Diabetes Metab
. 2003 Oct;
29(4 Pt 1):412-7.
PMID: 14526269
Objectives: To investigate if a dipeptide made of glutamine and alanine is able to contribute to the recovery from insulin-induced hypoglycaemia in type 1 diabetes. Research Design And Methods: Fifteen...
6.
Radermecker R, Magis D, Selam J, Scheen A
Rev Med Liege
. 2003 May;
58(3):164-7.
PMID: 12723510
The improvement of diabetic patients' glycaemic status requires an increase of fingerstick blood glucose measurements. Among the possibilities available to assess diabetes' control, we will consider new systems of continuous...
7.
Selam J
Diabetes Metab
. 2002 Mar;
27(5 Pt 3):S28-32.
PMID: 11910977
French type 2 diabetic patients are underinsulinised mainly because of fear of injections. Among all alternatives to the subcutaneous route, only the lung has a sufficient bioavailability of 10% without...
8.
Boulton A, Selam J, Sweeney M, Ziegler D
Diabetologia
. 2001 Nov;
44(10):1296-301.
PMID: 11692178
Aims/hypothesis: Ninety percent of all men with diabetes have Type II (non-insulin-dependent) diabetes mellitus, and erectile dysfunction (ED) is common in this patient group. This study evaluated the effects of...
9.
Boillot J, Bardin C, ZIRINIS P, Coste A, Escudier E, Chast F, et al.
Diabet Med
. 2001 Sep;
18(8):614-8.
PMID: 11553197
Aims: We have evaluated the local tolerance and the metabolic efficacy of a lyophilized nasal insulin preparation in 10 severely hyperglycaemic Type 2 diabetic patients. Methods: The study included two...
10.
Taverna M, Pacher N, Bruzzo F, Slama G, Selam J
Diabet Med
. 2001 Sep;
18(7):584-8.
PMID: 11553190
Background And Aims: Secondary failure to oral hypoglycaemic agents, a common evolution of long-standing Type 2 diabetes, is usually assessed by non-standardized indices requiring fine clinical assessment, including hyperglycaemia resistant...